Renal Cell Carcinoma
Roundtables
Management strategies in advanced RCC Roundtable
Conference Coverage
Most community-based oncologists skip biomarker testing
Survey shows that 48% of community clinicians use biomarker testing to guide treatment decisions, compared with 73% of academic clinicians.
From the Journals
Immunotherapy for cancer patients with poor PS needs a rethink
Patients should not receive immunotherapy just to reduce risk of side effects, doctor says.
Latest News
‘Dawn of a new era’ in the treatment of renal cell carcinoma
Monotherapy with pembrolizumab was associated with significantly longer disease-free survival after nephrectomy than placebo in a trial of 994...
Latest News
FDA OKs belzutifan for cancers tied to von Hippel–Lindau disease
The treatment was approved for patients with von Hippel–Lindau disease undergoing treatment for renal cell...
Latest News
One in three cancer articles on social media has wrong info
Physician says misleading information online may be harmful to patients.
From the Journals
Hyperprogression on immunotherapy: When outcomes are much worse
Clinical Insights
Steroid-refractory pneumonitis from ICIs: Experience at major centers
From the Journals
Don’t delay: Cancer patients need both doses of COVID vaccine
For patients with cancer, immune response to the first dose of the Pfizer COVID-19 vaccine is reduced, and there is a need for a booster dose at...
Clinical Insights
mCODE: Improving data sharing to enhance cancer care
Clinical Insights
How has the pandemic affected rural and urban cancer patients?